Healthcare & Medical Devices Global On demand · 24-48h

Global Artificial Intelligence Endoscope Market Strategic Research Report

Global Artificial Intelligence Endoscope Market Strategic Re…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Artificial Intelligence Endoscope Market
$1.31B2025
27%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Lesion Detection Type, Lesion Characterization Type, Blind-Spot Monitoring Type, Workflow Quality-Control Type, Multi-Function Integrated Type

By Application: Colorectal Cancer Screening, Early Upper Gastrointestinal Cancer Screening, Gastrointestinal Polyp Detection, Real-Time Lesion Recognition Assistance, Endoscopy Quality Control Management, Teaching and Training

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Olympus Corporation, Fujifilm Holdings Corporation, Karl Storz SE & Co. KG, Medtronic plc, Stryker Corporation, Hoya Corporation, Johnson & Johnson, Boston Scientific Corporation, Shenzhen Sonoscape Medical Corp., Shanghai Aohua Endoscopy Co., Ltd., Ankon Medical Technologies (Wuhan) Co., Ltd., Chongqing Jinshan Science & Technology (Group) Co., Ltd., MicroPort Scientific Corporation, Wuhan Chujingling Medical Technology Co., Ltd., Shenzhen Innomed Medical Technology Co., Ltd.

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 114 pages
Market size 2025
$1.31B
Billion USD
Forecast CAGR
27%
2025-2032
Forecast 2032
$7B
Projected
リージョン
5
Asia Pacific · Latin America · MEA · Europe · North America

概観

Scope of the Report

The global Artificial Intelligence Endoscope market size is predicted to grow from US$ 1,315 million in 2025 to US$ 7,005 million in 2032; it is expected to grow at a CAGR of 27.0% from 2026 to 2032.

An AI endoscope is an endoscopic device integrated with AI software that analyzes images and videos in real-time to assist physicians during procedures. It uses machine learning to detect and characterize lesions, improve polyp detection rates, and enhance procedural quality and efficiency by compensating for human error and variability.

In 2025, the global production of AI endoscopes was 32,000 units, with an average price of US$42,000 per unit.

Global key Artificial Intelligence Endoscope players cover Olympus Corporation, Fujifilm Holdings Corporation, Karl Storz SE & Co. KG, Medtronic plc, Stryker Corporation, etc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Artificial Intelligence Endoscope market?

What factors are driving Artificial Intelligence Endoscope market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Artificial Intelligence Endoscope market opportunities vary by end market size?

How does Artificial Intelligence Endoscope break out by Type, by Application?

This report presents a comprehensive overview of the global Artificial Intelligence Endoscope market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Lesion Detection Type
  • Lesion Characterization Type
  • Blind-Spot Monitoring Type
  • Workflow Quality-Control Type
  • Multi-Function Integrated Type

Segment by System Integration Method

  • External Module Type
  • Processor-Integrated Type
  • Software Platform Type
  • Cloud-Edge Collaborative Type

Segment by Analysis Timing

  • Real-Time Analysis Type
  • Near-Real-Time Analysis Type
  • Offline Analysis Type

Segment by Application

  • Colorectal Cancer Screening
  • Early Upper Gastrointestinal Cancer Screening
  • Gastrointestinal Polyp Detection
  • Real-Time Lesion Recognition Assistance
  • Endoscopy Quality Control Management
  • Teaching and Training

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Artificial Intelligence Endoscope market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Colorectal Cancer Screening, Early Upper Gastrointestinal Cancer Screening, Gastrointestinal Polyp Detection evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Artificial Intelligence Endoscope Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 27%
Regional growth momentum
Market share by segment
Key metrics
Base value
$1.31B
2025
Forecast
$7B
2032
CAGR
27%
2025–2032
リージョン
5
global
Key companies
Olympus CorporationFujifilm Holdings CorporationKarl Storz SE & Co. KGMedtronic plcStryker CorporationHoya CorporationJohnson & JohnsonBoston Scientific Corporation
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Lesion Detection TypeLesion Characterization TypeBlind-Spot Monitoring TypeWorkflow Quality-Control TypeMulti-Function Integrated Type
By Application
Colorectal Cancer ScreeningEarly Upper Gastrointestinal Cancer ScreeningGastrointestinal Polyp DetectionReal-Time Lesion Recognition AssistanceEndoscopy Quality Control ManagementTeaching and Training

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Lesion Detection Type
  • 3.1.3 Lesion Characterization Type
  • 3.1.4 Blind-Spot Monitoring Type
  • 3.1.5 Workflow Quality-Control Type
  • 3.1.6 Multi-Function Integrated Type
  • 3.1.7 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Colorectal Cancer Screening
  • 4.1.3 Early Upper Gastrointestinal Cancer Screening
  • 4.1.4 Gastrointestinal Polyp Detection
  • 4.1.5 Real-Time Lesion Recognition Assistance
  • 4.1.6 Endoscopy Quality Control Management
  • 4.1.7 Teaching and Training
  • 4.1.8 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Olympus Corporation
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Fujifilm Holdings Corporation
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Karl Storz SE & Co. KG
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Medtronic plc
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Stryker Corporation
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Hoya Corporation
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Johnson & Johnson
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Boston Scientific Corporation
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Shenzhen Sonoscape Medical Corp.
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Shanghai Aohua Endoscopy Co., Ltd.
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Ankon Medical Technologies (Wuhan) Co., Ltd.
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Chongqing Jinshan Science & Technology (Group) Co., Ltd.
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 MicroPort Scientific Corporation
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Wuhan Chujingling Medical Technology Co., Ltd.
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Shenzhen Innomed Medical Technology Co., Ltd.
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Artificial Intelligence Endoscope market?
The global Artificial Intelligence Endoscope market is estimated at US$ 1.31 billion in 2025 (base year) and is projected to reach US$ 7 billion by 2032.
What is the forecast CAGR for the Artificial Intelligence Endoscope market?
The market is expected to grow at a CAGR of 27.0% from 2026 to 2032, expanding from US$ 1.31 billion in 2025 to US$ 7 billion in 2032, roughly 5.3 times its base-year value.
What is Artificial Intelligence Endoscope?
An AI endoscope is an endoscopic device integrated with AI software that analyzes images and videos in real-time to assist physicians during procedures. It uses machine learning to detect and characterize lesions, improve polyp detection rates, and enhance procedural quality and efficiency by compensating for human error and variability.
How is the Artificial Intelligence Endoscope market segmented by type?
By type, the market is segmented into Lesion Detection Type, Lesion Characterization Type, Blind-Spot Monitoring Type, Workflow Quality-Control Type and Multi-Function Integrated Type.
What are the key applications of Artificial Intelligence Endoscope?
Key applications covered include Colorectal Cancer Screening, Early Upper Gastrointestinal Cancer Screening, Gastrointestinal Polyp Detection, Real-Time Lesion Recognition Assistance, Endoscopy Quality Control Management and Teaching and Training.
Which companies are profiled in the Artificial Intelligence Endoscope market report?
Key players profiled include Olympus Corporation, Fujifilm Holdings Corporation, Karl Storz SE & Co. KG, Medtronic plc, Stryker Corporation, Hoya Corporation, Johnson & Johnson and Boston Scientific Corporation, among 15 companies covered in total.
What geographies does the Artificial Intelligence Endoscope market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Artificial Intelligence Endoscope?
What factors are driving Artificial Intelligence Endoscope market growth, globally and by region?
Who should buy the Artificial Intelligence Endoscope market report?
The report is intended for manufacturers and solution providers, distributors and end users in Colorectal Cancer Screening, Early Upper Gastrointestinal Cancer Screening and Gastrointestinal Polyp Detection, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Artificial Intelligence Endoscope market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

All data sources are cited within the report. View our full research methodology →
Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.